Literature DB >> 12798609

Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice.

Joon Lin Chew1, Claudia Betina Wolfowicz, Hai-Quan Mao, Kam W Leong, Kaw Yan Chua.   

Abstract

Our previous studies indicated that intramuscular (i.m.) immunisation with full length Der p 1 cDNA induced significant humoral response to the left domain (approximately corresponding to amino acids 1-116) but not to the right domain (approximately corresponding to amino acids 117-222) of Der p 1 allergen. This study explored the use of chitosan-DNA nanoparticles for oral immunisation to induce immune responses specific to both the left and right domains of Der p 1. DNA constructs pDer p 1 (1-222) and pDer p 1 (114-222) were complexed with chitosan and delivered orally followed by an i.m. injection of pDer p 1 (1-222) 13 weeks later. Such approach has successfully primed Th1-skewed immune responses against both domains of Der p 1. This strategy could be further optimised for more efficacious gene vaccination for full length Der p 1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798609     DOI: 10.1016/s0264-410x(03)00228-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

Review 1.  Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?

Authors:  Roudayna Diab; Chiraz Jaafar-Maalej; Hatem Fessi; Philippe Maincent
Journal:  AAPS J       Date:  2012-07-06       Impact factor: 4.009

Review 2.  Polymeric nanoparticle drug delivery technologies for oral delivery applications.

Authors:  Eric M Pridgen; Frank Alexis; Omid C Farokhzad
Journal:  Expert Opin Drug Deliv       Date:  2015-03-26       Impact factor: 6.648

3.  Oral gene application using chitosan-DNA nanoparticles induces transferable tolerance.

Authors:  Katja Goldmann; Stephan M Ensminger; Bernd M Spriewald
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

Review 4.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

Review 5.  Adjuvants for allergy immunotherapeutics.

Authors:  Carlos Gamazo; Carmen D'Amelio; Gabriel Gastaminza; Marta Ferrer; Juan M Irache
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 6.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

7.  Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles.

Authors:  Katherine Bowman; Rita Sarkar; Sanj Raut; Kam W Leong
Journal:  J Control Release       Date:  2008-06-27       Impact factor: 9.776

8.  Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.

Authors:  Irina Kadiyala; Yihua Loo; Krishnendu Roy; Janet Rice; Kam W Leong
Journal:  Eur J Pharm Sci       Date:  2009-11-12       Impact factor: 4.384

9.  Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption.

Authors:  Yong-yan Bei; Xiao-yan Chen; Yang Liu; Jing-yu Xu; Wen-juan Wang; Zong-lin Gu; Kong-lang Xing; Ai-jun Zhu; Wei-liang Chen; Lin-seng Shi; Qin Wang; Xue-nong Zhang; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2012-04-03

Review 10.  Chitosans for delivery of nucleic acids.

Authors:  Michael D Buschmann; Abderrazzak Merzouki; Marc Lavertu; Marc Thibault; Myriam Jean; Vincent Darras
Journal:  Adv Drug Deliv Rev       Date:  2013-07-18       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.